Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Conditions: Pancreas Cancer; Pancreatic Cancer; Cancer of the Pancreas Interventions: Biological: Neoantigen Peptide Vaccine; Drug: Poly ICLC; Procedure: Blood for immune monitoring Sponsors: Washington University School of Medicine; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Pancreas | Pancreatic Cancer | Research | Vaccines